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We present molecular and protein proﬁling of all acetylcholine receptors (ACh-R) in human scalp skin using PCR,
in situ hybridization and double-labeling immunoﬂuorescence. Within the epidermis, the nicotinic (n)ACh-R subunits,
a3, a5, b2, and b4 were expressed in the basal cell layer (BCL) and in a single cell layer in the stratum granulosum;
a9 was expressed in the basal and lower spinous layers. a7, a10, and b1 were preferentially detected in the upper
spinous and granular layers. Of the muscarinic (m)ACh-R, m1 and m4 were found in the suprabasal layers, whereas
m2, m3, and m5 remained restricted to the lower layers. In the outer root sheath of the hair follicle, all ACh-R except
a9, b1, and m4 were found in the BCL whereas the a9, m4, and m5 ACh-R were restricted to the central cell layer. The
a5, b1, b2, m1–m4 chains were strongly expressed in the inner root sheath. Undifferentiated sebocytes expressed
the a3, a9, b4, m3–m5 ACh-R whereas a7, b2, b4, m2, and m4 were found in mature sebocytes. In sweat glands, the
a3, a7, and m2–m5 ACh-R were most prominent in the myoepithelial cells whereas a9, b2, m1, m3, and m4 ACh-R
were present in the acinar cells. Taken together, our data result in a complete molecular map of the extraneuronal
cholinergic system of the skin that may be translated into distinct functional reaction patterns.
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Epidermal differentiation is a highly complex process that
can be influenced by various factors such as calcium ions,
vitamin A or D, growth hormones or cytokines (Fuchs,
1990). Acetylcholine (ACh-R) and its nicotinic (nACh-R) and
muscarinic (mACh-R) receptors are produced extraneuron-
ally in the tegumental cells covering the inner and outer
surfaces of the body. ACh has been found to influence the
terminal differentiation of keratinocytes that produce, store,
secrete, and degrade this transmitter (Grando et al, 1993).
ACh is degraded by acetycholinesterase (AChE), one of
most potent enzymes in the human body that is present in
high concentration in the blood (Wessler et al, 1999). Con-
sequently, ACh can only act as a local cytotransmitter in an
autocrine or paracrine fashion. In contrast, choline, the main
degradation product of ACh is stable and can act ‘‘hor-
mone-like’’ over longer distances (Papke et al, 1996; Al-
kondon et al, 1997; Grando, 1997). It is well established that
keratinocytes grow better in culture if choline is present and
hence virtually all culture media for keratinocytes contain
104–105 M choline chloride (Gordon et al, 1988). Re-
cently, it has been proposed that ACh is also involved in
‘‘apoptotic secretion’’, a process that occurs during the
transition of differentiating keratinocytes from the stratum
granulosum to the stratum corneum (Nguyen et al, 2001).
Human nACh-R are composed of different subunits, i.e.
a1–a10, b1–b4, g, d, and e that can be combined to
pharmacologically distinct pentameric ion channels. The a1,
b1, g (only fetal), d and e (adult) chains form heteropentam-
ers present at the neuromuscular junction. The neuronal
heteropentamers that contain the a3 subunit together with
other subunits are also termed a3 nACh-R. The a7 and a9
subunits form homopentamers and are mainly permeable
for calcium whereas the a3 nACh-R are also permeable for
other ions like sodium or potassium. (Lukas et al, 1999;
Millar, 2003). Recently it has been suggested that a9 sub-
units may form heteromeric nACh-R together with a10 sub-
units (Sgard et al, 2001). Depending on their subunit
composition, the nACh-R show different affinities to ACh,
choline, and other cholinergic compounds like nicotine.
Therefore, it is crucial to exactly map the distribution of the
subunits in human epidermis if their function is to be elu-
cidated under physiological and pathological conditions. So
far, in the epidermis, mRNA of the a3, a5, a7, a9, a10, b2,
and b4 subunits has been found by PCR. The exact dis-
tribution of the nACh-R, however, on mRNA and protein
levels has remained vague (Raftery et al, 1980; Elgoyhen
et al, 1994; Grando et al, 1995; Nguyen et al, 2001; Sgard
et al, 2001; Arredondo et al, 2002).
Hitherto, five molecular subtypes of mACh-R have been
identified. They are single subunit, transmembrane glyco-
proteins, of which m2 and m4 are coupled to G-proteins of
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the Gi family that upon activation lead to inhibition of aden-
ylatcyclase. The m1, m3, and m5 subunits are coupled to
G-proteins of the Gq class and act specifically over signa-
ling cascades on phospholipase C or D, thus regulating in-
tracellular calcium levels. The mACh-R have been mapped
to different layers of the epidermis, their functional role,
however, has remained elusive (Grando et al, 1995; Ndoye
et al, 1998; van Koppen and Kaiser, 2003).
Since the extraneuronal cholinergic system has been
implied in basic functions of the skin such as terminal dif-
ferentiation and barrier formation, sweat and sebum secre-
tion and microcirculation (Longmore et al, 1985; Smith et al,
1992; Schafer et al, 2001; Arredondo et al, 2002), we ex-
amined ACh-R gene expression in human skin on the mRNA
and protein levels. Using affinity purified polyclonal antisera
raised in different species, we performed colocalization
studies, providing an exact map of the ACh-R composition
in scalp epidermis and adnexal structures that may be
translated into distinct functional reaction patterns.
Results
Presence of ACh-R mRNA in human skin: PCR We first
analyzed the presence of ACh-R mRNA in the skin by PCR
and in situ hybridization (ISH). Using PCR, specific signals
for the a1, a2, a4, a6, and b3 nACh-R could not be amplified
from human scalp split skin cDNA. a8 subunits only occur in
chicken and were therefore not examined. In contrast, for all
mACh-R and the a3, a5, a7, a9, a10, b1, b2, and b4 nACh-
R, specific bands could be amplified (Fig 1). The identity of
all bands was of expected sizes and was confirmed by se-
quencing. In cDNA samples of human skin from other body
sites, including back, leg and footsole, there was a consid-
erable, reproducible variability in the results obtained. In
cDNA from back skin we did not detect m1 and m3 but m2,
m4, and m5 ACh-R mRNA (not shown). Amplification of
pyruvate dehydrogenase (PDH) yielded only a single band
of 101 bp, indicating the absence of genomic DNA. Hence,
reaction products obtained for the intronless mACh-R can
be considered to result from mRNA transcripts.
Distribution of nACh-R mRNA in human skin detected
by non-radioactive ISH (NR-ISH) We focused our interest
on the nACh-R, since the distribution of the mACh-R
seemed to be less controversial. We found a prominent a3
mRNA signal in the basal cell layer (BCL) and in the stratum
granulosum. In the stratum spinosum the staining intensity
varied considerably, in some specimens being truly nega-
tive. Myoepithelial cells of sweat gland acini and ductal cells
were brightly labeled (Fig 2a); a5 signals were restricted to
the basal and immediately suprabasal layers. Only in some
sections, single cells in the stratum granulosum also pro-
duced a strong signal (Fig 2b). Myoepithelial cells of sweat
gland acini and ductal cells were brightly labeled. a7 signals
were enriched in the upper stratum spinosum and in the
stratum granulosum (Fig 2c). In the upper outer root sheath
(ORS), there was a strong signal in the BCL. In sweat
glands, a strong signal could be detected in myoepithelial
cells of the acini and in luminal cells of the ducts. a9 labeling
could be detected in the BCL of all specimens examined
(Fig 2d ). The suprabasal layers were variably stained, in
some sections reaching to the stratum granulosum. b1 re-
activity could be detected in the BCL of the upper ORS. In
the epidermis, the strongest staining was found in the upper
stratum spinosum and in the stratum granulosum (Fig 2e).
There was no reactivity in sweat glands and sebaceous
glands. b2 signals were generally weak and predominantly
found in the epidermal BCL; in some sections, there was an
additional signal from single cells in the stratum granulosum
(not shown). b4 showed an extremely variable labeling pat-
tern; in some sections the strongest signal could be found in
the BCL (Fig 2f ), whereas in other sections, the strongest
signals were found in the stratum spinosum and stratum
granulosum.
Immunolocalization of Ach-R: general observations
Having determined the presence of different ACh-R mRNA
in the epidermis, we performed extensive immunolocaliza-
tion studies with ACh-R antisera from different species and
different sources (own, Biotrend, Santa Cruz, Sigma-Ald-
rich). For all sera tested, there was a considerable difference
in staining intensity and in staining quality depending on the
fixation method used. For most sera, the best results were
achieved using unfixed or acetone fixed sections. Particu-
larly Biotrend sera did not yield the expected (and pub-
lished) results if the recommended fixation method, 4%
paraformaldehyde containing 7% sucrose was applied.
From all the Santa Cruz nACh-R sera tested, only the
rabbit a5 serum yielded a reproducible staining of the ep-
idermal BCL. All other sera did not produce specific
immunofluorescence signals in human scalp skin with any
of the fixation methods used. Acetone fixed mouse brain
that was used as positive control showed strong signals.
Whether these were specific, could not be assessed in the
context of this study. We therefore excluded all Santa Cruz
sera from immunolocalization studies.
Analyzing skin specimens from different body sites, we
found interindividually and intraindividually highly variable
staining patterns. Therefore, we focused our studies on
scalp skin of middle-aged non-smokers. A summary of all
immunolocalization results is provided in Table III.
Figure 1
Amplification of acetylcholine receptors (ACh-R) mRNA from scalp
skin. Using PCR, specific signals could be produced for the m1–m5
muscarinic ACh-R (mACh-R) and a3, a5k, a7, a9, a10, b1, b2, and b4
subunits from non-smoker’s scalp skin. All bands correspond to ex-
pected sizes. Amplification of a10 transcript using the same a10 prim-
ers and PCR conditions as described by Sgard et al (2002), yielded the
expected band of 394 bp that can also be amplified from pituitary
glands together with an as yet unidentified band of  320 bp. K, pos-
itive control; PDH, specific band at 102 bp indicating absence of con-
taminating genomic DNA; 0, negative control (no cDNA).
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Immunolocalization of mACh-R in normal epidermis
The m1 ACh-R could reliably be localized with Biotrend
sera producing a membrane staining pattern in the upper
stratum spinosum and stratum granulosum. Our own m1
serum, GP20a, and the Sigma-Aldrich rabbit m1 serum
produced a more cytoplasmic staining of exactly the same
cells as the Biotrend serum (Fig 3a). The m2 antiserum
produced a prominent labeling of nerves and smooth
muscle cells. In addition, a weak staining of the epidermal
BCL was found. A strong staining of the stratum corneum
was considered unspecific (Fig 3b). Using a monoclonal
m2 antibody from Sigma-Aldrich, all fixation methods pro-
duced a nuclear stain. In addition, methanol fixed sections
showed a prominent labeling of the epidermal granular
layer. The m3 and m5 ACh-R antisera predominantly labeled
the BCL (Fig 3c, e), whereas the m4 antisera produced
a cytoplasmic staining of all suprabasal epidermal layers
(Fig 3d ).
Figure 2
Localization of acetylcholine receptors (ACh-
R) mRNA in human scalp skin by in situ hy-
bridization. The a3 mRNA is abundant in myo-
epithelial cells of eccrine sweat glands (a). The
a5 (b) and b4 (f) mRNA is localized predominantly
in the epidermal basal layer and in a single cell
layer of the stratum granulosum (arrows). The a7
signal is strongest in the granular and upper
spinous layers. In the basal layer, there is only a
weal signal (c). Note that on other sections, the
a7 signal in the basal layer is stronger. The a9
mRNA is most abundant in the basal layer and
decreases as the keratinocytes differentiate (d).
b1 mRNA can readily be detected in the up-
permost epidermal layers (e). Non-radioactive
in situ hybridization using nickel enhanced 3,30-
diaminobenzidine (DAB) as chromogen. Scale
bar: 50 mm.
Figure 3
Immunolocalization of muscarinic acetylcholine receptors (mACh-R) protein in human scalp epidermis. The muscarinic ACh-R isoforms
show a differentiation-dependent localization in the epidermis. Although m1 is predominantly found in the upper stratum spinosum and in the
stratum granulosum (GP20a, a), the m2 isoform (Biotrend) only faintly labels the epidermal basal layer. The strong signal in the stratum corneum is
unspecific and cannot be reduced by preincubation with the respective peptide. The m3 isoform shows a prominent labeling of the basal layer
(Biotrend, b). The m4 antisera produced a more cytoplasmic staining of suprabasal epidermal layers (Biotrend, d) and the m5 isoform is pre-
dominantly found in the basal layer, colocalizing with m3 (GP12b, e, same section as c). Scale bars: (a, b) 50 mm, (c–e) 100 mm.
CUTANEOUS CHOLINERGIC SYSTEM 939123 : 5 NOVEMBER 2004
Immunolocalization of nACh-R in normal epider-
mis There was a reproducible and strong staining of the
epidermal BCL for the a3 and b4 subunit antisera (Fig 4a).
The intensity of the a5 and b2 antisera in the BCL was highly
variable, even in different parts of the same section. In ad-
dition to the localization in the BCL, we found a cytoplasmic
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colocalization of the a3, a5, and b2 and, to a lesser extent,
also of the b4 chains in a single cell layer of the stratum
granulosum, especially in parts of the epidermis with prom-
inent keratohyaline granules (Fig 4e). In order to identify the
nature of this cell layer, we performed colocalization studies
using a filaggrin antibody (Fig 4f ). The filaggrin reactivity,
however, was clearly more extended than the b2 reactivity.
Our own a7 and a9 nACh-R antisera showed a clear
membrane staining, for the a7 nACh-R in the stratum gran-
ulosum and upper stratum spinosum and for the a9 nACh-R
in the lower stratum spinosum and stratum basale (Fig 4b).
In some sections our a7 serum GP9a also produced a var-
iable staining of the epidermal BCL, which was exclusively
labeled by the Biotrend a7 serum (Fig 4d ). In the granular
and BCL, there was a striking colocalization of the a7 sera
with the tight junction protein ZO1 (Fig 4d ). All a10 antisera
produced a variable staining of the BCL and a membrane
staining of the granular layer, paralleling a7 expression
(Fig 4b0). There was only a partial colocalization with our a9
nACh-R serum (Fig 4b00). Using a rat monoclonal antibody
against the b1 chain, we could demonstrate a membrane
staining in the stratum granulosum and upper stratum
spinosum. The b1 chain seemed to exactly colocalize with
the a7 nACh-R (Fig 4c) whereas there was no colocalization
with the a9 chain (not shown). Neither a7 nor b1 showed a
colocalization with the heterooligomers in the stratum gran-
ulosum (not shown). The distribution of the different ACh-R
in human scalp skin is summarized in Fig 5.
Immunolocalization of ACh-R in cutaneous
adnexal structures
Hair follicles The different compartments of human anagen
hair follicles were selectively labeled by the different ACh-R
antisera. In the infundibulum, we found an epidermis-like
pattern for all antisera examined, with increased intensity
especially for the a5, a10, b2, m3, and m5 antisera. In the
subinfundibular ORS the a3, a5, b2, b4, m1, and m3 sera
strongly immunolabeled the BCL whereas the central cell
layer (CCL) was only weakly labeled and the companion
layer (CL) remained negative (Fig 6a). Our GP9a- and the
Biotrend a7 serum decorated the BCL whereas only the
GP9a serum also weakly labeled the CL. In the bulbus area,
the ORS is reduced to a single cell layer, which was labeled
by the Biotrend a3, b4, m3, our a7 (GP9a), and m5 (GP12b)
sera (Fig 6a, c,e). The a10 sera weakly immunolabeled the
BCL of the ORS and showed a bright staining of the inner
root sheath (IRS) (not shown). The b1 antibody exclusively
immunostained the CL and the IRS, showing a partial co-
localization with the desmosomal cadherin desmocollin 1
(Fig 6b). The a9 and m5 antisera produced a membrane
staining of the CCL whereas the BCL and the CL remained
negative. The m4 serum yielded a more cytoplasmic stain-
ing of the CCL.
Apart from the b1 and a10 chain, only the a5, b2, m1, m2,
m3, and m4 sera strongly immunostained the IRS (espe-
cially Huxley’s layer, Fig 6d ), whereas a3 and b4 sera only
produced a weak staining. In contrast, the trichocytes that
form the hair shaft were brightly labeled with a3, b4, a9, m2,
m3, m4, and m5 sera (Fig 6a–f ). In telogen follicles and in
the bulge area of anagen follicles, we observed a strong
immunostaining with all b2 sera (Fig 7b). The matrix cells
were only stained with the a5, a9, m3, and m4 sera.
Sebaceous glands Undifferentiated sebocytes of the basal
glandular layer were brightly immunolabeled by a3, b4, a9,
m3, m4, and m5 antisera (Fig 7a,b), whereas a5, a7, and b2
sera only produced weak immunostaining and b1 and m2
remained immunonegative. The mature sebocytes of the
central glandular layers reacted with a7, b2, b4, m2, and m4
antisera (Fig 7c, d ). The sebaceous duct showed a partic-
ularly strong staining for a5, a7, and m3 sera, whereas a3,
a9, and m5 sera produced only a moderate staining.
Sweat glands In myoepithelial cells of sweat gland acini, we
found a prominent staining of a3, b2, b4, a9, a10, m2, m3,
Figure 4
Immunolocalization of nicotinic acetylcholine receptors (nACh-R)
protein in human scalp epidermis. The heterooligomers a3 (GP5a, a)
and b4 (Biotrend, a0) show complete colocalization in the epidermal
basal layer (a00). The homooligomer a9 (GPT1) is immunolocalized to the
basal layer and the stratum spinosum (b) whereas rabbit serum a10 VIb
produces a membrane staining pattern predominantly in the basal and
granular layers (b0) showing only partial colocalization with a9. a7 (c)
and b1 (c0) seem to exactly colocalize (c00) in the granular layer. In con-
trast, the tight junction protein ZO1 (d0) is localized in exactly the same
cells, but shows side by side localization with a7 (GP9a). Note that both
a7 and ZO1 show a dual localization in the basal, upper spinous layers
and in the stratum granulosum (d00). Apart from their variable localiza-
tion in the epidermal basal layer, a5 (GP1a, e) and b2 (Biotrend, e0)
colocalize in a single cell layer in the stratum granulosum (e00). The
differentiation-related antigen filaggrin is also expressed in the granular
layer (f) whereas b2 is restricted to single cells in the upper granular
layer and also shows a weak expression in the basal layer (f0). Colo-
calization of filaggrin and b2 in single cells (f00). Scale bar: 50 mm.
Figure5
Schematic presentation of acetylcholine receptors (ACh-R) distri-
bution in human scalp epidermis. On the basis of our in situ hybrid-
ization and immunofluorescence data, the distribution of ACh-R in
human scalp epidermis can be summarized as follows: in the basal
layer, there is a variable expression of the a3, a5, b2, and m2. The
strongest expression in most specimens was found in the basal layer
for the a3, b4, a9, a10, m3, and m5 chains whereas a5, b2, a7, and m2
chains showed a highly variable and often very weak expression in-
tensity. In the lower spinous layer only the a9 and m4 chains could be
detected in all specimens whereas m3 and m5 expression was variable.
In the upper spinous layer and in the stratum granulosum, the a7, a10,
b1, m1, and m4 chains predominate. In some specimens, also the m3
and m5 expression reaches up to this height. In the cytoplasm of a single
cell layer of the upper stratum granulosum, the a5 and b2 predominate,
but in some specimens, also a3 and b4 colocalize in these cells.
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m4, and m5 sera whereas a5, a7, and m1 sera produced a
less intense staining. The identity of myoepithelial cells was
confirmed by their characteristic shape and by colocaliza-
tion with a-smooth muscle actin (Fig 8a, d ). The acinar cells
were only weakly labeled by a9, a10, b2, m1, m3, and m4
sera. The sweat duct epithelium was brightly immunolabeled
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by a3, b2, b4, a7, a10, m4, and m5 sera, whereas the a5, a9,
m1, and m3 sera only produced a weak staining. In some
sections m3 immunostaining was pronounced in the BCL of
the sweat duct epithelium. The b1 chain was not detected in
sweat glands or sweat ducts (Fig 8).
Discussion
Starting from the pioneering work of Grando and cowork-
ers, we attempted to molecularly and phenotypically char-
acterize the complete extraneuronal cholinergic system of
the skin as a prerequisite for further functional studies. Us-
ing PCR, we confirmed the previously reported presence of
a3, a5, a7, a9, a10, b2, and b4 nACh-R and of m1, m3–m5
mACh-R mRNA in human skin (Grando et al, 1995; Ndoye
et al, 1998; Nguyen et al, 2000). In addition, we could un-
equivocally demonstrate the presence of b1 nACh-R mRNA
and protein in human epidermis. In contrast we were not
able to demonstrate the presence of a2, a4, a6, b3 nACh-R
mRNA in human skin. The presence of m2 mACh-R in PCR
experiments is explained by the obvious m2 expression in
cutaneous adnexal structures. In good agreement with pre-
vious studies and in contrast to oral squamous epithelium,
epidermis from scalp skin only shows a faint m2 staining of
the BCL together with an unspecific signal in the stratum
corneum (Ndoye et al, 1998; Arredondo et al, 2003).
By immunohistochemistry and ISH, there seems to be a
highly variable expression of the nACh-R in the epidermis,
especially of the heterooligomeric species of the a3 type.
To date, we were not able to systematically elucidate
the factors that cause this variability in expression of the
heterooligomeric nACh-R subunits observed in different
studies and between different specimens within a single
study. Putative factors include age, atopic disposition,
smoking habits or minimal trauma. In choosing only one
body site, i.e. the scalp, and excluding smokers from our
study, we were able to reduce the previously observed var-
iability significantly. Differences in body site might also ex-
plain contrasting results obtained with the same antibodies
(e.g. anti-a3, -b2) by other authors (Grando et al, 1995).
Of the nACh-R subunits, the a3, a5, b2, and b4 chains all
colocalize in the BCL of the epidermis and are hence able to
form a functional ACh-R. To variable amounts, they also
colocalize in a single cell layer of the stratum granulosum,
producing a more cytoplasmic staining. In this layer, we
found a strong reaction for the a5 and b2 chains that are
known to alter the pharmacological properties of the ACh-R
(Gerzanich et al, 1998; Curtis et al, 2000), whereas the a3
and b4 chains were less frequently detected. The cytoplas-
mic colocalization of different heterooligomers in a single
cell layer of the stratum granulosum has not been observed
before. The special layer in which they occur is localized in
the upper stratum granulosum as judged by filaggrin (Fig 4f )
and CK2e expression. It is a remarkable observation that
the a3, a5, b2, and b4 subunits as well as the a7, a10, and
b1 subunits show a distinct, but overlapping pattern of ex-
pression in the granular layer.
The homooligomeric nACh-R subunits a7 and a9 show a
clearly distinct distribution within the epidermis. Although
the a9 ACh-R are prominent in the BCL and lowest supra-
basal layers, the a7 ACh-R can be found in the upper stra-
tum spinosum and in the stratum granulosum, clocalizing
with the a10 and b1 chain. Normally, the b1 chain, together
with the a1, g, d, e chains, forms the ACh-R present at the
neuromuscular junction. There has been only been one
previous report in which b1 mRNA was detected in an ep-
ithelial cell line (Summers et al, 2003). It is completely un-
clear, whether the b1 chain, alone or together with other
subunits, can form a functional ACh-R in the epidermis. An
attractive possibility would be the association of the b1
subunit with the a7 chain, an assumption favored by the
exact colocalization of the two isoforms in the upper epi-
dermis. In other epithelial compartments of the skin, how-
ever, these isoforms do not colocalize, e.g. in hair follicles
(compare Table III). Hence, the b1 isoform might also form
homooligomeric nACh-R in human epidermis. The a10 sub-
unit is the most recent member of the epidermal ACh-R
subunits. Together with the a9 chain it forms functional Ach-
R in various organs (Sgard et al, 2002; Lips et al, 2002).
Much to our surprise, we found that in the epidermis a10
expression parallels a7 and b1 expression rather than a9
nACh-R subunit expression. In the other compartments of
the skin, there was a complete dissociation of the expres-
sion patterns for these four subunits (i.e. a7, a9, a10, and
b1) indicating that either a10 might be able to form func-
tional receptors with different subunits, or that a10 like b1
might be able to form functional receptors on its own, which
however has never been demonstrated in vitro (Elgoyhen
et al, 2001). Interestingly, a9 and a10 expression is also
differentially regulated in fetal development, at least in the
rat cochlea (Morley and Simmons, 2002). Therefore, the
functional relevance of the a10 and b1 nACh-R in human
epidermis remains to be determined.
The granular layer shows the highest concentration of
ACh throughout the epidermis. In conjunction with the fact
that the highest calcium concentrations within the epider-
mis have also been demonstrated in the granular layer
Figure 6
Distribution of acetylcholine receptors (ACh-R) in human anagen
hair follicles. The heterooligomers b2 (GP14a, a0) and b4 (Biotrend, a00)
colocalize in the outer root sheath (ORS) of anagen hair follicles with
predominance in the basal layer. In the inner root sheath (IRS), the b2
serum shows a stronger reaction in the Huxley’s layer (arrow in a),
whereas there is only a weak b4 staining (a00). The signal in matrix cells
and trichocytes is hardly above background. The rat mab against b1
specifically stains the entire IRS (b, b00), whereas in the ORS, there is
only a weak staining of the companion layer. The staining pattern re-
sembles the desmosomal protein desmocollin 1 (mab Dsc1-U100),
which also specifically stains the IRS, although with stronger intensity in
the lower parts of the follicle (b0). There was a strong reaction of the b1
mab in the basement membrane zone of the dermal papilla (b00). In large
parts of the epidermis and the ORS, m3 (c0, Biotrend) seems to co-
localize (arrow in c) with the desmosomal protein desmoglein 2 (c00,
mab Dsg2-G96). In the bulb area, however, a dissociation becomes
evident: whereas desmoglein 2 is not expressed in matrix, IRS and
trichocytes (c00), m3 shows a prominent staining of IRS and trichocytes
(c0). M4 is broadly expressed in the anagen follicle, as evidenced by the
Biotrend serum (d00). In the IRS, m4 colocalizes with the desmosomal
protein desmoglein 1 (d, d0). M2 shows only a weak staining of the ORS,
whereas the IRS is prominently labeled (Biotrend, e0). M3 (f0, Biotrend)
colocalizes with m5 (GP12b) in the ORS and trichocytes (yellow color in
f ) whereas in the matrix and IRS, m5 is only weakly expressed (e00, f00).
Scale bars: (a, c, e, f ) 150 mm, (b) 100 mm, (d ) 50 mm.
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(Denda et al, 2003), expression of homooligomeric nACh-R
such as a7 that preferentially gate calcium suggests that
they are involved in modulating terminal keratinocyte dif-
ferentiation and barrier function (Fuchs, 1990; Takeichi,
1990; Seguela et al, 1993). Apoptotic secretion is another
process within the granular layer that may be influenced by
ACh possibly mediated by a3 complexes in this special
localization (Nguyen et al, 2001).
To date, there has been no data available on ACh-R ex-
pression in hair follicles or sebaceous glands. One previous
Figure 7
Expression of acetylcholine receptors (ACh-R) in sebaceous glands. Like in the epidermis, the a3 (GP5b, a0) and b4 (Biotrend, a00) isoforms
colocalize in the basal layer of the sebaceous gland (a). Note that only b4 (a00) is expressed in the mature sebocytes (arrow in a) where it colocalizes
with a5 (not shown). The b2 serum (GP14a, b0) immunolabels the epidermal and sebaceous basal layers. Note a strong upregulation in club cells of a
telogen follicle whereas b4 reactivity does not change compared with the epidermal basal layer. Although in the epidermis, a7 and b1 show an
almost identical staining pattern, only a7 (GP9a, c00) is expressed in mature sebocytes, b1 remains negative (c0). In sebaceous glands a9 (GPT1, d0)
and a10 (a10 VIb, d00) show only partial colocalization in the basal layer, where both subunits produce a bright immunostaining. Only the a10 subunit
is found in mature sebocytes (d). The ‘‘inhibitory’’ muscarinic ACh-R (mACh-R) m2 (Biotrend, f 0) and m4 (Biotrend, e00) are both up-regulated in
mature sebocytes as compared with undifferentiated sebocytes of the basal seboglanular layers, whereas the ‘‘stimulatory’’ mACh-R m3 (not
shown) and m5 (GP12b, e0, f 00) are both expressed in basal sebocytes. Note single cells that show strong expression of m4 and m5 (arrows in e).
Scale bar: 100 mm.
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study focused on the high-affinity choline transporter 1,
which can be found in the epidermis and in cells of the IRS
(Haberberger et al, 2002). We found a highly complex ex-
pression pattern of the different ACh-R subunit genes in the
epithelial compartments of human hair follicles and seba-
ceous glands, showing some analogy to established sys-
tems of differentiation markers, like the desmosomal
cadherins (Kurzen et al, 1998). Although the a7, a10, and
the b1 subunits show precise colocalization in the upper
epidermis, their expression patterns in the hair follicle
Figure 8
Expression of acetylcholine receptors (ACh-R) in human eccrine sweat glands. (a) The nicotinic ACh-R b2 (Biotrend, a00) is strongly expressed in
myoepithelial cells of sweat glands, as indicated by their characteristic shape and by colocalization (a) with a-smooth muscle actin (mab HHF35, a0).
The acinar cells remain negative. Both a3 (GP5a, b00) and b4 (Biotrend, b0) show a strong reaction in the myoepithelial cells and a weaker reaction in
the acinar cells. Note the strong reaction in the epithelial cells lining the sweat duct (arrow in b). The a9 chain (GPT1, c0) incompletely colocalizes with
a10 (a10 VIb) in the sweat glands, often displaying a side by side pattern (arrow in c). Vessels (Ves) are exclusively labeled by a10 sera. The
muscarinic m1 receptor is only weakly expressed in the myoepithelial and acinar cells, the ductal cells show a stronger reaction (d00). Identification of
myoepithelial cells via a-smooth muscle actin (d0). Comparison of m2 (Biotrend, e0), m3 (Biotrend, f00), and m5 (GP12b, e00, f0) reveals a predominance
of these isoforms in the myoepithelial cells as indicated by yellow coloring in (e) and (f). In addition m3 is expressed in the acinar cells (arrow in f on
green pseudocolor). Vessels are prominently m2 immunopositive (arrow in e). Note strong m5 expression in the outer root sheath of an adjacent hair
follicle in (e). Scale bar: 50 mm.
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diverge: the a7 and a10 subunits are confined to the BL and
CL of the ORS, whereas b1 is confined to the CL. In the IRS
a10 and b1 both show a strong expression whereas a7
remains negative. Of all the nACh-R, only the a9 shows a
strong expression in the CCL of the ORS. The only other
Ach-R found in this layer are the m4 and m5 mACh-R. The
b1 shows a strong expression in the CL and in the IRS, a
pattern reminiscent of the desmosomal cadherin des-
mocollin 1. In colocalization studies, however, we could
demonstrate that both proteins do not fully colocalize. Des-
mocollin 1 is slightly further extended both in the epidermis
and in the hair follicle (Fig 6b). Like in the epidermis, the a9
and m3 chains showed pattern reminiscent of desmoglein 2
and 3 (Kurzen et al, 1998) with broad expression in the ORS
and the trichocytes of the hair shaft. But again, on close
inspection, a dissociation of the different pattern becomes
evident with m3 being expressed also in the IRS. In addi-
tion, high magnification of laser scan overlay images re-
vealed side by side and not ‘‘true’’ co-staining.
The heterooligomeric subunits were mostly confined to
the BCL of the ORS, with b2 being particularly strongly ex-
pressed in the bulge area, where the hair stem cells are
suspected to reside (Lyle et al, 1999). Taking into account
the complex biology of the hair follicle, clearly further stud-
ies are needed to clarify the influence of ACh and ACh-R on
hair cycle and hair growth (Stenn and Paus, 2001).
Smoking is known to negatively influence several skin
diseases, especially acne vulgaris (Schafer et al, 2001).
Since sebum production is closely linked to the develop-
ment of acne lesions, effects of chronic nicotine exposure
on the course of acne lesions might be mediated by nACh-R
present in sebaceous glands, resulting in increased sebum
production or altered sebum composition. It has to be kept
in mind, however, that cigarette smoke contains a plethora
of different toxins, making it difficult to attribute an observed
clinical effect to one component (Mills et al, 1993) and
hence effects of smoking might not completely correspond
to effects of nicotine. In this respect, further studies are
needed. We could demonstrate an upregulation of the
‘‘inhibitory’’ mACh-R m2 and m4 in mature sebocytes as
compared with undifferentiated sebocytes of the basal
seboglanular layers, whereas the ‘‘stimulatory’’ mACh-R m3
and m5 are both expressed in basal sebocytes. Together
with the presence of the nACh-R this finding strongly
advocates for ACh as a secretagogue for sebum production
and a promotor of sebocyte differentiation.
The anatomy of eccrine sweat glands has been known
for some decades, whereas sweat gland innervation has
been a difficult research area, depending mainly on phar-
macologic observations. It is well established that sweat
glands respond to innervation by the sympathicus, a proc-
ess mediated presynaptically by adrenergic receptors (Re-
chardt et al, 1976). The postganglionic sympathetic neurons
terminating in close proximity to the myoepithelial cells of
eccrine sweat glands, release ACh and at the same time
produce acetylcholinesterase (Ostlere et al, 1995). It could
be shown that sweat production can be blocked effectively
using both antiadrenergic and anticholinergic compounds.
Sweating, on the other hand, can be induced by injection of
ACh, nicotine, carbachol (which activates all ACh-R and
blocks AChE) and other cholinomimetic compounds. This
effect can be antagonized by atropine and not by hex-
amethonium bromide, an unspecific nACh-R antagonist.
This observation together with results obtained in different
animals led to the assumption that mostly m3 and m4
mACh-R were mainly involved in sweat generation (Long-
more et al, 1985; Sato and Sato, 1987; Grant and Landis,
1991; Smith et al, 1992). Our results unequivocally demon-
strate the presence of both nACh-R and mACh-R in myo-
epithelial and acinar cells of eccrine sweat glands. This
finding indicates that sweat production in the acinar cells
and sweat expulsion through contraction of myoepithelial
cells are mediated by different nACh-R and mACh-R.
Altogether, we could demonstrate a highly regulated dis-
tribution of nACh-R subunits and mACh-R isoforms in
human scalp epidermis and adnexal structures supporting
previously observed effects of cholinergic compounds on
keratinocyte biology (Grando et al, 1995; Nguyen et al,
2001). Our data provide the basis for further research on the
role of the cholinergic system in hair biology, sebaceous
gland biology, and sweat gland biology.
Materials and Methods
Tissues Normal human non-smoker’s skin (scalp, back, leg) was
obtained after informed consent from the margins of routine sur-
gical procedures. Samples were frozen in isopentane cooled in
liquid nitrogen immediately after removal and stored at 801C or
fixed in 4% buffered formaldehyde and embedded in paraffin.
PCR RNA was extracted from split skin (depth 2 mm) using the
RNeasy fibrous tissue Kit according to the manufacturer’s instruc-
tions (Qiagen, Hilden, Germany). cDNA was synthesized from
freshly isolated mRNA after DNAse treatment using Superscript II
(Life Technologies, Eggenstein, Germany). In addition, a human
footsole (epidermis and dermis) cDNA library was used (Kurzen
et al, 1998). For PCR analyses 100 ng of the respective cDNA and
20 pmol primers were used per 25 mL reaction tube. Hot start PCR
was performed using AmpliTaq Gold (Applied Biosystems, We-
iterstadt, Germany) according to standard protocols on a Peltier
thermal cycler (MJ Reearch Inc., Waltham, Massachusetts). The
annealing temperature was optimized for all primer pairs and
ranged from 551C to 641C (Table I). PCR products were visualized
on standard 2.5% agarose gels with ethidium bromide. Amplified
products of expected sizes were excised from the gels, purified
(QIAquick PCR Purification Kit, Qiagen), cloned using the TOPO TA
Cloning Kit (Invitrogen, Karlsruhe, Germany) and sequenced (A.
Hunzicker, German Cancer Research Center Heidelberg). To ex-
clude contaminating genomic DNA, PDH (Acc.#: XM_113395)
primers that produce fragments of 102 bp in the presence of cDNA
and fragments of 200 bp in presence of genomic DNA were used.
All PCR experiments were performed at least twice.
ISH Cloned nACh-R cDNA from PCR experiments was used to
produce digoxigenin (DIG)-labeled antisense and sense (negative
control) cRNA according to the manufacturer’s instructions (DIG
RNA Labeling kit, Roche, Mannheim, Germany). A positive control
was provided by the manufacturer. Labeling intensity was control-
led using a dot blot procedure. Labeled cRNA was detected us-
ing a horseradish-coupled anti-DIG antibody (Dianova, Hamburg,
Germany) and the ECL System (Amersham, Freiburg, Germany).
ISH was performed at least twice on 9 mm cryostat sections,
fixed RNAse free in 4% buffered paraformaldehyde containing 5%
sucrose. After thorough washing, proteinase K digestion (20 min)
and prehybridization (60 min, 371C), ISH was performed over night
at 421C–541C using 10–30 mg DIG-labeled cRNA per slide. After
intense washing, non-hybridized cRNA was removed by RNAse
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digestion. Hybridized cRNA was detected using a biotin-coupled anti-
DIG antibody (Dianova), peroxidase-coupled streptavidin (Dianova)
and nickel enhanced 3,30-diaminobenzidine Sigma-Aldrich (Munich,
Germany) as chromogen. Sections were embedded after dehydration
using Entellan (Merck, Darmstadt, Germany) and analyzed under a
Leitz Diaplan photomicroscope (Leitz, Wetzlar, Germany).
Immunoﬂuorescence staining of human skin For immunofluo-
rescence analysis, 5 mm cryostat sections of human skin from var-
ious body sites were either used air dried and unfixed or fixed
either in ice-cold acetone or in freshly prepared 3% buffered for-
maldehyde containing 7% sucrose. Immunofluorescence reactions
were performed at least 10 times on different specimens according
to standard procedures (Kurzen et al, 2002). After blocking with 5%
non-fat dry milk and 1% BSA in Tris-buffered saline (TBS), the
primary antibodies were applied to the specimens for 1 h at room
temperature or for 12 h at 41C. The following secondary antibodies
were applied for 1 h at room temperature: Cy-2- and Cy-3-coupled
preabsorbed goat anti-mouse, anti-rabbit, and anti-guinea-pig an-
tisera and a Cy-3-coupled rabbit anti-goat antiserum, all obtained
from Dianova.
In order to enhance the signal intensity, biotin-coupled sec-
ondary antibodies were used. Antibody binding was visualized with
Cy-2- or Cy-3-coupled streptavidin (Dianova). Negative controls
were performed by replacing the primary antibody with phosphate-
buffered saline (PBS) or an irrelevant, species-matched antibody.
Washes (310 min) were performed after each step in PBS or
TBST. Preincubation of all guinea-pig sera with a 5-fold molar ex-
cess of the respective peptide used as immunogen was performed
Table I. Primer pairs used for PCR analysis of ACh-R expression
ACh-R Forward primer Reverse primer Position
Product
size
Annealing
temperature (1C)
m1 AAT GCG CTC TTC ACC AGG AA GGC TCT GCC TAT GAA GCG AG 2017–2280 263 55
m2 CCA AGT CTG GTA CAA GGA AG CTC CAC CGT GGT ATT AGT TG 697–1035 338 55
m3 GCA GAT GGA CCA AGA CCA CAG GGT AGA GTG GCC GTG CTC TTA 975–1364 389 64
m4 CGG TGC TGT ACA TCC ACA TCT CTC TGT GGT GGA CAG CTC TGT G 635–948 313 64
m5 CAA TGA CCA CAG TCA ACA TC GAG TCA CTG TTC ATT GTT AC 828–1248 420 55
a1 CAT CAA GTA CAT CGC AGA GA TTC TCT GCT CTG GTA GGT TC 1242–1474 233 55
a2 GGA GCT CTG CCA CCC CCT AC AAC ATA CTT CCA GTCC TC 1715–2042 327 64
a3 AGG CCA ACA AGC AAC GAG TTG CAG AAA CAA TCC TGC TG 1258–1677 419 64
a4 GCT TCT CCC TGG ACT CTG TG AGG GGA GAG CTG GAC TTA GC 2195–2412 218 60
a5 TCA ACA CAT AAT GCC ATG GC CCT CAC GGA CAT CAT TTT CC 1181–1400 219 64
a6 AGG CTC TGA TGC AGT GCC CA AAT TAT AAA TAC CCA AAGA 1141–1465 324 64
a7 CTT CAC CAT CAT CTG CAC CAT C GGT ACG GAT GTG CCA AGG ATA T 1503–1810 308 55
a9 ATC CTG AAA TAC ATG TCC AGG G AAT CGG TCT ATG ACT TTC GCC 1037–1389 352 64
a10 CTC TCA AGC TGT TCC GTG ACC AAG GCT GCT ACA TCC ACG C 161–555 394 64
b1 TGT ACC TGC GTC TAA AAA GG TCA ACC CTC CAG TCT TC 1083–1538 455 60
b2 GCT CTT CAT GCA GCA GCC ACG CC TCA CTC ACG CTC TGG TCA TC 1302–1610 308 61
b3 ATG TGG ATC GCT ACT ACT C GAT GTC AGG TCT AAG GTG TA 950–1317 367 64
b4 TGT GAG CAT TGG CCA TCA AC AAT GCC AAG CCT CTG AGC TG 1713–2026 313 55
PDH GGT ATG GAT GAG GAG CTG GA CTT CCA CAG CCC TCG ACT AA 142–243 101/200 55
Product size in base pairs. Annealing temperature used for PCR that yielded specific bands of expected sizes. 200, in the case of PDH product size
varies depending on the presence of genomic DNA.
ACh-R, acetylcholine receptors; PDH, pyruvate dehydrogenase.
Table II. Guinea-pig antisera generated against ACh-R
Antigen Peptide Domain
Designa-
tion
m1 330-CTKKGRDRAGKGQKP-343 C3 GP20a
m3 290-CSSYELQQQSMKRSN-304 C3 GP19b
m4 286-CPVADKDTSNFSSSG-299 C3 GP16a
m5 1-MEGDSYHNATTVNGC-14 E1 GP12b
a3 207-IIKAPGYKHDIKYNC-221 E1 GP10a
386-SKGCKEGYPCQDGMC-400 C2 GP5b
a5 202-CLEDQDVDKRDFFDN-215 E1 GP2a
378-EETESGSGPKSSRCN-391 C2 GP1a
a7 412-CSPTHDEHLLHGGQPP-427 C2 GP9a
a9 81-WHDAYLTWDRDQYDRLD-97 E1 GPT1
115-NKADDESSEPVNTN-128
b2 487-TCTTTFLHSDHSAPSSK-502 E3 GP14a
b4 484-QCTHAASEGPYAAQRD-498 E3 GP17a
E1 and C3 denote domains of the respective protein from which the
peptide used for immunization was chosen. All sera displayed showed a
strong reactivity with the antigen, immunofluorescence reactivity could be
completely eliminated by preincubation with the immunogen.
ACh-R, acetylcholine receptors.
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routinely for 6 h at 371C in PBS. The staining was observed and
visualized with a Laser Scan Confocal Microscope (LSCM; Type
LSM 510 UV, Zeiss, Jena, Germany).
Production of antisera against ACh-R The following peptides
were used to immunize guinea-pigs according to standard proto-
cols. Peptides from the first and third extracellular domain (E1, E3)
and the second (nACh-R) and third (mACh-R) cytoplasmic domain
(C2, C3), which have only limited similarity to other isoforms, were
selected. Peptides were chosen in order to minimize possible
cross-reactivities and to maximize antigenicity and solubility. Two
animals were immunized with each peptide. Only in the case of the
a9 chain, both peptides were mixed and injected into two animals.
The sera obtained were screened by a dot blot procedure for re-
activity with the immunogens. High titer sera were affinity purified
against the immunogen peptides using the AminoLink Immobiliza-
tion Kit (Pierce, Bonn, Germany). The guinea-pig sera displayed in
Table II shows a strong reaction with the immunogen and produces
a membrane staining in immunofluorescence, which was en-
hanced after affinity purification and absent after preincubation
with the respective peptide (Table II).
Additional antibodies used In addition to our own guinea-pig
antisera, we analyzed commercially available affinity-purified an-
tisera from Santa Cruz Biotechnologies (Heidelberg, Germany):
rabbit anti-a3 (sc-5590), a7 (sc-5544), m1 (sc-9106), m4 (sc-9109),
and m5 (sc-9110), goat anti-a3 (sc-1771), a5 (sc-9345), a7 (sc-
1447), m1 (sc-7470), m3 (sc-7474), m4 (sc-7476), and m5 (sc-
7478); Biotrend (Cologne, Germany): rabbit anti-a3 (AS-5611S), a5
(AS-5621S), a7 (AS-5631S), b2 (AS-5646S), b4 (AS-5656S), m1
(AS-3701S), m3 (AS-3741S), m4 (AS-3761S), and m5 (AS-3781S).
The Biotrend sera correspond to those published by Grando et al
(1995) and Ndoye et al (1998). M2 rabbit antiserum corresponding
to AS-3721S from Biotrend was a kind gift of S. A. Grando (San
Francisco). Rat monoclonal anti-b1 (clone 111) and polyclonal
rabbit anti-M2 (No.: 9559) were from Sigma-Aldrich. The a10 an-
tisera a10 I (rabbit), a10 VIb (rabbit), a10V (guinea-pig), were kind
gifts of W. Kummer (Gieen, Germany). Characterization of the a10
antisera has been published in Lips et al (2002), mab HHF35
against a-smooth muscle actin (Enzo Diagnostics, Farmingdale,
New York), mab 15C10 against filaggrin (Novocastra, Newcastle,
UK), mab Dsc1-U100 against desmocollin 1, mab Dsg1-P124
against desmoglein 1, mab Dsg2-G96 against desmoglein 2 (all
from Progen, Heidelberg, Germany).
We would like to thank Monika Engstner for expert technical assistance
and Oliver Jahraus, Institute of Immunology, for providing access to the
Laser scan facilities.
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Table III. Summary of ACh-R expression in human non-smoker’s scalp skin
m1 m2 m3 m4 m5 a3 a5 a7 a9 a10 b1 b2 b4
Epidermis
BCL  (þ ) þ  þ þ þ / þ þ þ þ  þ / þ
SPL þ  þ þ þ    þ M (þ )   
GRL þ   þ  þ / CP þ / CP þ M  þ þ M þ / CP þ / CP
Hair follicle
ORS
BCL þ þ þ  þ þ þ þ  þ  þ B þ
CCL (þ )  (þ ) þ þ    þ þ    
CL  þ  þ   (þ ) þ  þ þ þ 
IRS  þ þ þ (þ ) þ þ   þ þ þ Hu (þ )
TC  þ þ þ þ þ   þ    
Matrix   þ þ (þ ) þ  þ    
Sebaceous gland
Basal   þ þ þ þ (þ ) (þ ) þ þ  þ þ
Suprabasal  þ  þ   þ þ  þ   þ
Duct   þ  þ þ þ þ þ þ  þ þ
Sweat gland
Myo (þ ) þ þ þ þ þ (þ ) (þ ) þ þ  þ þ
Acinar þ  þ þ  þ   þ þ   þ
Duct (þ )  þ þ þ þ (þ ) þ (þ ) þ  þ þ
B, bulge; BCL, basal cell layer; CCL, central cell layer; CL, companion layer; CP, cytoplasmic staining of a single cell layer; GRL, granular cell layer;
IRS, inner root sheath; M, membrane staining; Myo, myoepithelial cells; ORS, outer root sheath of the subinfundibular hair follicle; SPL, spinous cell
layer; TC, trichocytes; þ , persistent expression; þ /, variable expression; (þ ), weak expression; , no expression; ACh-R, acetylcholine receptors.
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